Liver transplantation for hepatocellular carcinoma

Surgery

Volumn 131, Issue 1 SUPPL., 2002, Pages

  Suehiro, Taketoshi ^a   Terashi, Takahiro ^a   Shiotani, Satoko ^a   Soejima, Yuji ^a   Sugimachi, Keizo ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 12;

AMYLOID NEUROPATHY; ARTICLE; BLEEDING; CADAVER; CHEMOTHERAPY; ELECTROPORATION; GENE THERAPY; HUMAN; JAPAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; LIVER RESECTION; LIVER TRANSPLANTATION; LIVING DONOR; ORGAN DONOR; PRIORITY JOURNAL; RECURRENT DISEASE; SURGICAL APPROACH; SURGICAL TECHNIQUE; SURVIVAL RATE; TREATMENT FAILURE; TREATMENT INDICATION;

EID: 0036165012     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1067/msy.2002.119575     Document Type: Article

References (45)

1. Results of 280 liver resections for hepatocellular carcinoma
2. Surgical indications for advanced hepatocellular carcinoma
3. Indication for palliative reduction surgery in advanced hepatocellular carcinoma: The use of a remnant tumor index
4. Surgical treatment strategy for patients with stage IV hepatocelludar carcinoma
5. Treatment of hepatocellular carcinoma associated with cirrhosis in the era of liver transplantation
6. Hepatic transplantation for primary and metastatic cancers of the liver
7. Liver transplantation for hepatocellular carcinoma: A proposal of a prognostic scoring system
8. FAP world transplant register and domino/sequential register update
9. Is hepatocellular carcinoma in cirrhosis an actual indication for liver transplantation?
10. Liver transplantation for the treatment of small hepatocellular carcinoma in patients with cirrhosis
11. A multidisciplinary approach to hepatocellular carcinoma in patients with cirrhosis
12. Role of adjuvant treatment in liver transplantation for advanced hepatocellular carcinoma
13. Multimodal treatment for hepatocellular carcinoma on cirrhosis: The role of chemoembolization and alcoholization before liver transplantation
14. Clinicopathologic features and postoperative prognosis of multicentric small hepatocellular carcinoma
15. Prognostic tactors after repeat hepatectomy for recurrent hepatocellular carcinoma
16. Clinicopathologic features of patients with hepatocellular carcinoma surviving >10 years after hepatic resection
17. A new surgical strategy for cirrhotic patients with hepatocellular carcinoma and hypersplenism: Performing a hepatectomy after a laparoscopic splenectomy
18. Treatment of small hepatocellular carcinoma
19. Is transplantation really superior to resection in the treatment of small hepatocellular carcinoma?
20. Resection or transplantation for hepatocellular carcinoma in cirrhotic patients: Outcomes based on indicated treatment strategy
21. Impact of histological grade of hepatocellular carcinoma on the outcome of liver transplantation
22. Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma
23. Liver transplantation for hepatocellular carcinoma
24. Single-center analysis of the first 40 adult-to-adult living donor liver transplants using the right lobe
25. Living donor liver transplantation in adults: Outcome in Japan
26. Living donor liver transplantation for early hepatocellular carcinoma: A life-expectancy and cost-effectiveness perspective
27. Sequential liver transplantation
28. Domino liver transplants for metabolic disorders: Experience with familial amyloidotic polyneuropathy
29. Domino liver transplantation from a living related donor
30. Sequential liver transplantation: 27 Cases in 25 patients
31. Domino split-liver transplantation from a living donor: Case reports on in situ and ex situ splitting
32. A pedigree analysis with minimized ascertainment bias shows anticipation in Met30-transthyretin related familial amyloid polyneuropathy
33. Familial amyloidotic polyneuropathy: Domino liver transplantation
34. Surgical manipulation of VX2 carcinoma in the rabbit liver evokes enhancement of metastasis
35. Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma
36. Temporary shunt between right portal vein and yena cava in living related liver transplantation
37. Cyclophosphamide-induced tolerance in rat orthotopic liver transplantation
38. Role of immunosuppression in recurrence after liver transplantation for diethylnitrosamine-induced tumors in rats
39. Tumor recurrence in liver grafts: Two animal models
40. Effect of systemic cyclosporine on tumor recurrence after liver transplantation in a model of hepatocellular carcinoma
41. Posttransplant infusion of donor-specific blood induces immunological unresponsiveness in rat hepatic allograft
42. CD45RC gamma delta T-cell infiltration is associated with immunologic unresponsiveness induced by prior donor-specific blood transfusion in rat hepatic allografts
43. Complete cure of established murine hepatocellular carcinoma is achievable by repeated injections of retroviruses carrying the herpes simplex virus thymidine kinase gene
44. Growth suppression of the hepatocellular carcinoma cell line Hepa 1-6 by an activatable interferon regulatory, factor-1 in mice
45. Electroporation-mediated interleukin-12 gene therapy for hepatocellular carcinoma in the mice model